Fresenius raises $39m

Fresenius (NYSE:FMS) has raised $39 million in a new round of equity financing, according to an SEC filing.

The company said that managers of the offering may require members to contribute capital from “time to time” in addition to the offering amount in proportion to the member’s respective ownership, if the issuer needs additional capital, according to the SEC filing.

The company has not yet said how it plans to use the money, which all came from 3 investors who have yet to be named.

Earlier this month, Fresenius said yesterday it rebranded its dialysis service division under the new name Fresenius Kidney Care.

With the move, Waltham, Mass.-based said it launched a new website for the business which offers education on dialysis, treatment options and other tailored information for people in various stages of kidney disease, the company said.

In March, Cardiovascular Systems (NSDQ:CSII) said it extended its supply deal with Fresenius for its ViperSlide lubricant, extending the agreement through April 4, 2021.

The extension to the agreement also gives Cardiovascular Systems final purchase rights upon the termination of the agreement or if Fresenius stops production of ViperSlide.

St. Paul, Minn.-based Cardiovascular Systems said the extended agreement included an update to the product pricing schedule as well, according to an SEC filing.

The post Fresenius raises $39m appeared first on MassDevice.

from MassDevice http://ift.tt/1SB6DXI